US Stock MarketDetailed Quotes
PTCT PTC Therapeutics
- 43.880
- -1.230-2.73%
Close Nov 29 13:00 ET
- 43.880
- 0.0000.00%
Post 17:01 ET
3.38BMarket Cap-7387P/E (TTM)
45.375High43.180Low428.78KVolume44.770Open45.110Pre Close18.80MTurnover0.71%Turnover RatioLossP/E (Static)77.13MShares47.24052wk High-3.21P/B2.66BFloat Cap23.58052wk Low--Dividend TTM60.71MShs Float78.720Historical High--Div YieldTTM4.87%Amplitude4.030Historical Low43.849Avg Price1Lot Size
PTC Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.11%196.79M | -12.68%186.7M | -4.66%210.12M | 34.20%937.82M | 83.41%307.06M | -9.46%196.58M | 29.17%213.81M | 48.17%220.38M | 29.75%698.8M | 1.32%167.41M |
| Operating revenue | 0.11%196.79M | -12.68%186.7M | -4.66%210.12M | 34.20%937.82M | 83.41%307.06M | -9.46%196.58M | 29.17%213.81M | 48.17%220.38M | 29.75%698.8M | 1.32%167.41M |
| Cost of revenue | 14.27%10.85M | 21.96%15.53M | 4.21%14.74M | 46.57%65.49M | 167.31%29.12M | -32.25%9.49M | 32.08%12.73M | 39.56%14.14M | 38.20%44.68M | 16.79%10.89M |
| Gross profit | -0.61%185.94M | -14.87%171.18M | -5.27%195.38M | 33.36%872.34M | 77.57%277.94M | -7.89%187.08M | 28.99%201.08M | 48.80%206.24M | 29.21%654.12M | 0.40%156.52M |
| Operating expense | -21.68%237.9M | -36.42%204.53M | -25.05%240.93M | 11.67%1.22B | -13.35%274.82M | 9.81%303.75M | 22.12%321.72M | 35.74%321.45M | 24.15%1.09B | 25.50%317.18M |
| Selling and administrative expenses | -9.19%73.46M | -21.42%69.5M | -15.70%73.27M | 2.01%332.54M | -17.72%76.29M | 0.96%80.89M | 10.71%88.45M | 18.62%86.91M | 14.08%326M | 7.13%92.72M |
| Research and development costs | -1.71%161.41M | -28.89%132.17M | -40.48%116.13M | 2.31%666.56M | -35.69%121.35M | -0.76%164.21M | 18.19%185.87M | 39.30%195.12M | 20.49%651.5M | 25.93%188.69M |
| Depreciation amortization depletion | -94.82%3.04M | -93.96%2.87M | 30.74%51.53M | 91.01%222.64M | 115.79%77.17M | 89.05%58.65M | 80.26%47.4M | 67.92%39.42M | 112.88%116.55M | 118.87%35.76M |
| -Depreciation and amortization | -94.82%3.04M | -93.96%2.87M | 30.74%51.53M | 91.01%222.64M | 115.79%77.17M | 89.05%58.65M | 80.26%47.4M | 67.92%39.42M | 112.88%116.55M | 118.87%35.76M |
| Operating profit | 55.46%-51.97M | 72.35%-33.36M | 60.46%-45.55M | 20.58%-349.4M | 101.94%3.12M | -58.75%-116.66M | -12.16%-120.64M | -17.30%-115.22M | -17.33%-439.93M | -65.92%-160.66M |
| Net non-operating interest income expense | -47.76%-41.61M | -47.85%-43.49M | -49.41%-40.83M | -42.16%-129.18M | -80.71%-44.28M | -34.87%-28.16M | -33.85%-29.42M | -16.23%-27.33M | -5.64%-90.87M | -8.88%-24.5M |
| Non-operating interest expense | 47.76%41.61M | 47.85%43.49M | 49.41%40.83M | 42.16%129.18M | 80.71%44.28M | 34.87%28.16M | 33.85%29.42M | 16.23%27.33M | 5.64%90.87M | 8.88%24.5M |
| Other net income (expense) | 79.71%-4.42M | 89.84%-8.89M | -77.62%1.69M | -283.71%-217.53M | -2,455.03%-115.9M | 33.72%-21.77M | -356.34%-87.42M | 4,974.84%7.56M | 1.19%-56.69M | 76.47%-4.54M |
| Special income (charges) | -69.60%-2.54M | 92.28%-6.86M | 104.17%100K | -2,941.93%-227.66M | -239.83%-134.86M | -128.30%-1.5M | -684.87%-88.9M | -120.51%-2.4M | -1,596.80%-7.48M | -427.97%-39.68M |
| -Less：Restructuring and merger&acquisition | -53.33%700K | 103.96%5.1M | -104.17%-100K | -393.05%-127.7M | -142.86%-2.7M | 128.30%1.5M | -748.03%-128.9M | 120.51%2.4M | -5,080.00%-25.9M | 152.07%6.3M |
| -Less:Impairment of capital assets | --1.84M | -99.19%1.76M | ---- | 552.41%217.8M | --0 | --0 | --217.8M | ---- | --33.38M | --33.38M |
| -Less:Other special charges | ---- | ---- | ---- | --137.56M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 90.76%-1.87M | -236.92%-2.03M | -84.02%1.59M | 120.59%10.13M | -46.05%18.96M | 46.87%-20.27M | 104.30%1.48M | 183.98%9.96M | 14.98%-49.21M | 212.02%35.15M |
| Income before tax | 41.18%-97.99M | 63.90%-85.73M | 37.26%-84.7M | -18.49%-696.11M | 17.21%-157.05M | -30.96%-166.59M | -59.71%-237.48M | -10.75%-134.99M | -13.34%-587.49M | -36.86%-189.69M |
| Income tax | 125.77%8.66M | 134.84%13.45M | 73.34%6.88M | -144.14%-69.51M | 93.30%-1.26M | -87.89%-33.62M | -1,237.85%-38.6M | -17.91%3.97M | -611.96%-28.47M | -503.78%-18.8M |
| Net income | 19.79%-106.65M | 50.13%-99.18M | 34.10%-91.58M | -12.09%-626.6M | 8.83%-155.79M | -21.64%-132.97M | -30.77%-198.88M | -9.65%-138.96M | -6.70%-559.02M | -19.28%-170.89M |
| Net income continuous Operations | 19.79%-106.65M | 50.13%-99.18M | 34.10%-91.58M | -12.09%-626.6M | 8.83%-155.79M | -21.64%-132.97M | -30.77%-198.88M | -9.65%-138.96M | -6.70%-559.02M | -19.28%-170.89M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 19.79%-106.65M | 50.13%-99.18M | 34.10%-91.58M | -12.09%-626.6M | 8.83%-155.79M | -21.64%-132.97M | -30.77%-198.88M | -9.65%-138.96M | -6.70%-559.02M | -19.28%-170.89M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 19.79%-106.65M | 50.13%-99.18M | 34.10%-91.58M | -12.09%-626.6M | 8.83%-155.79M | -21.64%-132.97M | -30.77%-198.88M | -9.65%-138.96M | -6.70%-559.02M | -19.28%-170.89M |
| Basic earnings per share | 21.02%-1.39 | 51.50%-1.29 | 36.17%-1.2 | -7.45%-8.37 | 12.34%-2.06 | -15.03%-1.76 | -24.88%-2.66 | -5.62%-1.88 | -4.85%-7.79 | -15.76%-2.35 |
| Diluted earnings per share | 21.02%-1.39 | 51.50%-1.29 | 36.17%-1.2 | -7.45%-8.37 | 12.34%-2.06 | -15.03%-1.76 | -24.88%-2.66 | -5.62%-1.88 | -4.85%-7.79 | -15.76%-2.35 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data